The prognostic value of CALM2 in STAD patients was determined through Kaplan-Meier Plotter (http://kmplot.com/analysis/), which signified that higher CALM2 level foreboded poorer overall survival and first progression survival of STAD patients instead of post progression survival (Figures 2A–C). The gene discussed is CALM2; the disease is gastric adenocarcinoma.